AMG National Trust Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

AMG National Trust Bank’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,049	Closed	-$1.07M	–	453
2023 Q2	$1.07M	Buy	3,049 +6	+0.2%	+$2.02K	0.04%	267
2023 Q1	$959K	Buy	3,043 +99	+3%	+$29.7K	0.03%	289
2022 Q4	$850K	Buy	2,944 +49	+2%	+$14.9K	0.03%	294
2022 Q3	$839K	Sell	2,895 -3	-0.1%	-$863	0.03%	290
2022 Q2	$816K	Buy	2,898 +24	+0.8%	+$6.42K	0.03%	288
2022 Q1	$750K	Sell	2,874 -239	-8%	-$56.7K	0.02%	306
2021 Q4	$684K	Sell	3,113 -41	-1%	-$7.97K	0.02%	325
2021 Q3	$572K	Buy	+3,154	New	+$616K	0.02%	339

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AMG National Trust Bank's VRTX Position: Q3 2023 in Review

AMG National Trust Bank sold out of Vertex Pharmaceuticals (VRTX) in Q3 2023, closing a stake of 3,049 shares — an estimated $1.07M sold.

AMG National Trust Bank first reported a position in VRTX in Q3 2021 and held it in 8 quarters. The position peaked at $1.07M in Q2 2023. 1,277 funds tracked by Wall St. Rank hold VRTX as of Q3 2023.

AMG National Trust Bank reported no remaining Vertex Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
AMG National Trust Bank sold 3,049 Vertex Pharmaceuticals shares in Q3 2023, an estimated $1.07M.
AMG National Trust Bank first reported a position in Vertex Pharmaceuticals in Q3 2021 and held it in 8 quarters.
AMG National Trust Bank's Vertex Pharmaceuticals position peaked at $1.07M in Q2 2023.
1,277 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2023.

Based on AMG National Trust Bank's 13F filing for Q3 2023, filed 8 Nov 2023.